Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort.

Rene ClaveroAlfredo Parra-LucaresGabriel Méndez-ValdésEduardo VillaKarin BravoEvelyn MondacaJosseline ArandaRose BrignardelloCynthia GajardoAngelica OrdenesEvelyn ColomboJessica TapiaAndoni EtcheverryJosé ZúñigaLuis Toro

Published in: Vaccines (2022)

Our results suggest that the CoronaVac vaccine induced a lower humoral response than the BNT162b2 vaccine in ESRD patients on hemodialysis.

Keyphrases

immune response
end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
prognostic factors
dendritic cells
toll like receptor
high glucose
cross sectional
oxidative stress
patient reported outcomes
drug induced
endothelial cells
double blind